Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
Jun Iwamoto1, Mitsuyoshi Uzawa2, Yoshihiro Sato3, Tsuyoshi Takeda1, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Orthopaedic Surgery, Keiyu Orthopaedic Hospital, Gunma, Japan; 3Department of Neurology, Mitate Hospital, Fu...
Main Authors: | Jun Iwamoto, Mitsuyoshi Uzawa, Yoshihiro Sato, Tsuyoshi Takeda, et al. |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-07-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/effects-of-short-term-combined-treatment-with-alendronate-and-elcatoni-a3323 |
Similar Items
-
Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
by: Jun Iwamoto, et al.
Published: (2010-04-01) -
Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
by: Jun Iwamoto, et al.
Published: (2008-09-01) -
The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01) -
Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
by: Fatemeh Khanizadeh, et al. -
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
by: Hiroaki Okamoto, et al.
Published: (2020-03-01)